Varenicline (sold as Chantix) is the most effective single medication for quitting smoking, with roughly double the one-year quit rate of bupropion (Zyban) in head-to-head studies. But “best” depends on your health history, side effects you’re willing to tolerate, and whether you need a prescription. There are three categories of FDA-approved options: nicotine replacement therapy (NRT), bupropion, and varenicline, and all three meaningfully improve your odds of quitting compared to willpower alone.
The Three Types of FDA-Approved Options
Every smoking cessation medication falls into one of three groups. Nicotine replacement therapy delivers small, controlled doses of nicotine without the thousands of harmful chemicals in cigarette smoke. It comes in five forms: patches, gum, lozenges (all available over the counter), plus a nasal spray and inhaler (both prescription). The other two options are prescription pills that don’t contain nicotine at all: bupropion and varenicline. Each works through a different mechanism, and your doctor can help match one to your situation.
Varenicline: The Strongest Single Option
Varenicline works by latching onto the same brain receptors that nicotine targets. It partially activates those receptors, which eases withdrawal cravings, while simultaneously blocking nicotine from binding to them. That means if you do slip and smoke a cigarette while taking it, the reward feeling is blunted. This dual action is why it tends to outperform other options.
In a study comparing the two prescription medications within a structured quit program, the one-year continuous quit rate was 13.9% for varenicline versus 6.2% for bupropion. That gap was statistically significant. When researchers measured a looser definition of success (whether participants had been smoke-free for the previous seven days at the one-year mark), the numbers were closer: 20.5% for varenicline and 18.6% for bupropion.
The standard course lasts 12 weeks. You start about a week before your planned quit date with a low dose that gradually increases over the first week, reaching the full dose by day eight. The most common side effect is nausea, which is why you take it after eating with a full glass of water. Some people also report vivid or unusual dreams. The FDA label carries warnings about possible mood changes, agitation, depressed mood, and suicidal thoughts, so it’s important to pay attention to how you feel emotionally during treatment and let someone close to you know you’re taking it.
Bupropion: A Good Alternative
Bupropion is an antidepressant that also reduces nicotine cravings and withdrawal symptoms. It doesn’t contain nicotine and works on different brain chemistry than varenicline. For people who can’t tolerate varenicline’s side effects, or who also deal with depression, bupropion can be a practical choice.
The main limitation is a list of conditions that rule it out entirely. You should not take bupropion if you have a seizure disorder, a history of eating disorders like anorexia or bulimia, or a history of serious brain injury including stroke or head trauma. Abrupt withdrawal from alcohol or benzodiazepines also raises seizure risk with this medication. If none of those apply to you, bupropion is a well-established option with decades of use behind it.
Nicotine Replacement Therapy: Flexible and Accessible
NRT is the most accessible route since patches, gum, and lozenges are available without a prescription. The idea is simple: you give your body a controlled, tapering supply of nicotine while you break the behavioral habit of smoking. Over weeks, you step down the dose until you’re nicotine-free.
Choosing the right starting strength matters. If you smoke your first cigarette within 30 minutes of waking up, you likely need the higher-strength version (4 mg gum or lozenge rather than 2 mg). The patch provides a steady background level of nicotine throughout the day, while gum and lozenges let you respond to sudden cravings as they hit.
Why Combination NRT Often Works Better
Using a single NRT product is the most common approach, but pairing two forms together, typically a patch for steady background relief plus gum or lozenges for breakthrough cravings, is notably more effective. Research comparing combination NRT to patch-only therapy found that the combination led to greater reductions in cravings and in the mental expectation that smoking would feel rewarding. The U.S. Preventive Services Task Force recognizes all three approaches (NRT, bupropion, and varenicline) as effective first-line treatments, and combination NRT has shown quit rates that approach those of varenicline in some studies.
How the Options Compare at a Glance
- Highest quit rates as a single medication: Varenicline, with roughly 14% continuous abstinence at one year in clinical settings.
- Good alternative, especially with depression: Bupropion, with about 6% continuous abstinence at one year (higher by looser measures).
- Most accessible, no prescription needed: NRT patches, gum, and lozenges. Best results come from combining a patch with a short-acting form like gum or lozenges.
- Best overall approach: Any of these medications combined with behavioral counseling. The USPSTF gives its highest recommendation (Grade A) to the combination of counseling and medication together.
Insurance Coverage and Cost
Under the Affordable Care Act, most health insurance plans are required to cover smoking cessation treatment without charging you a copay or deductible. This includes all FDA-approved medications, both prescription and over-the-counter, when prescribed by a healthcare provider. Plans must cover at least two quit attempts per year, with each attempt including a 90-day supply of medication and four counseling sessions of at least 10 minutes each, with no prior authorization required. If your insurer is pushing back on covering a cessation medication, they may be out of compliance with federal rules.
Grandfathered health plans (those that existed before the ACA and haven’t made major changes) are exempt from this requirement, so it’s worth checking your specific plan details.
A Medication Not Yet Available in the U.S.
Cytisine is a plant-based medication that works similarly to varenicline and has been used for smoking cessation in parts of Europe for decades. It’s available in at least 18 countries and became a prescription option in the UK in early 2024. Its U.S. manufacturer planned to seek FDA approval, but the agency requested additional long-term safety data, pushing the timeline back by at least a year. Early evidence suggests it causes less nausea than varenicline. If it eventually reaches the U.S. market, it could become an important alternative, particularly given that varenicline has faced supply shortages in recent years.
Picking the Right Fit
If you want the statistically strongest option and don’t mind a prescription, varenicline is the evidence-based frontrunner. If you have a history of seizures or eating disorders that rules out bupropion, or if nausea from varenicline is intolerable, combination NRT (patch plus gum or lozenges) gives you competitive quit rates without a prescription for the core products. Bupropion makes the most sense when you also want support for mood, or when the other options haven’t worked or aren’t suitable.
No medication works well in isolation. Pairing any of these with some form of counseling, whether that’s a telephone quitline, an app-based program, or in-person sessions, consistently improves outcomes beyond medication alone. Most people who eventually quit for good have tried multiple times, so a failed attempt with one medication doesn’t mean the next one won’t work.